Skip to main content

Mylan has another ally in its battle against Teva takeover

Consumer advocacy groups on Tuesday urged the Federal Trade Commission to block Teva Pharmaceutical’s hostile bid for generic drug maker Mylan NV, saying the takeover would result in higher drug prices and reduced manufacturing capability...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.